eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2013
vol. 17
 
Share:
Share:
abstract:
Original paper

otal antioxidant status in plasma of breast cancer women in relation to ERβ expression

Miłosława Maria Zowczak-Drabarczyk
,
Dawid Murawa
,
Leszek Kaczmarek
,
Karol Połom
,
Maria Litwiniuk

Contemp Oncol (Pozn) 2013; 17 (6): 499-503
Online publish date: 2013/11/25
View full text Get citation
 
PlumX metrics:
Aim of the study: The aim of this pilot study was to evaluate the plasma total antioxidant capacity (TAS) in breast cancer patients in relation to ERβ expression.

Material and methods: The study group consisted of newly diagnosed consecutive female breast cancer patients

(n = 41) and controls (n = 28) randomly selected from women with benign breast disease. TAS was determined with the ABTS reagent. Immunostaining for ERβ was performed using polyclonal antibodies. ER, PgR and HER-2 were measured routinely (immunostaining for ER and PgR with monoclonal antibodies and EnVision detection system; immunohistochemical method/FISH for HER-2 expression).

Results: The plasma TAS was significantly decreased in the breast cancer patients in comparison to the controls independently of hormonal and lymph node status. The TAS level was not significantly different between breast cancer subgroups either in relation to the ERβ expression (ERβ+ vs. ERβ–) or considering the steroid receptor status (ER+, ERβ+, Pg+ vs. ER+, ERβ–, Pg+) even in the selected lymph node negative subgroup. Similarly, HER-2 expression did not significantly affect the TAS concentration. A tendency towards higher TAS level in all ERβ negative breast cancer subgroups was observed.

Conclusions: The results might confirm enhanced consumption of plasma antioxidants in breast cancer patients. The determination of ERβisoforms along with parameters of redox status might enable better understanding of their mutual influence
keywords:

total antioxidant status, oxidative stress, breast cancer, estrogen receptor, estrogen receptor β

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.